Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 23, 2017 07:00 ET | Source: Asterias Biotherapeutics

Asterias Biotherapeutics Opens Additional Clinical Site for AST-OPC1 SCiStar Study

FREMONT, Calif., Aug. 23, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that...
August 14, 2017 16:10 ET | Source: Asterias Biotherapeutics

Asterias Biotherapeutics Reports Second Quarter Financial Results and Reviews Recent Clinical Progress and Corporate Developments

- Achieved meaningful progress with key clinical programs; multiple milestones anticipated during remainder of 2017- - Conference Call and Webcast Today, August 14, at 4:30 p.m. ET - FREMONT,...
August 14, 2017 07:00 ET | Source: Asterias Biotherapeutics

Asterias Announces Major AST-VAC2 Development Milestone: First cGMP-Compliant Lot Successfully Manufactured to Support First Clinical Study of AST-VAC2

FREMONT, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that Cancer...
August 09, 2017 07:00 ET | Source: Asterias Biotherapeutics

Asterias Enrolls First Patient in Final Cohort of SCiStar Clinical Trial

FREMONT, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced enrollment...
August 08, 2017 07:00 ET | Source: Asterias Biotherapeutics

Former Quadriplegic Enrolled in Asterias’ SCiStar Study to Throw Ceremonial First Pitch at Major League Baseball Game

FREMONT, Calif., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST) today announced that Lucas Lindner of Eden, Wisconsin, a quadriplegic patient who has regained...
August 07, 2017 07:00 ET | Source: Asterias Biotherapeutics

Asterias Biotherapeutics to Present at Canaccord Genuity Growth Conference on August 10, 2017

FREMONT, Calif., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that Mike...
August 03, 2017 07:00 ET | Source: Asterias Biotherapeutics

Asterias Biotherapeutics Opens Two Additional Clinical Sites for AST-OPC1 SCiStar Study

FREMONT, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that two...
July 31, 2017 07:00 ET | Source: Asterias Biotherapeutics

Asterias Biotherapeutics to Report Second Quarter Results on August 14, 2017

FREMONT, Calif., July 31, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that...